56,455 Shares in Ventas, Inc. $VTR Purchased by Advisors Preferred LLC

Key Points

• Advisors Preferred LLC opened a new position in Ventas, buying 56,455 shares in Q4—about $4.37 million worth of stock.
• Several brokerages raised price targets and ratings recently (Wells Fargo, RBC, KeyCorp, Morgan Stanley), leaving Ventas with an average analyst target of $91.73 and a consensus rating of "Moderate Buy" (13 Buys, 3 Holds).
• Ventas raised its quarterly dividend to $0.52 (annualized $2.08) from $0.48, implying a ~2.4% yield on current prices.

Advisors Preferred LLC acquired a new position in shares of Ventas, Inc. (NYSE:VTR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 56,455 shares of the real estate investment trust's stock, valued at approximately $4,366,000.

Several other institutional investors and hedge funds have also recently modified their holdings of VTR. Cloud Capital Management LLC purchased a new stake in shares of Ventas in the 3rd quarter valued at about $25,000. GoalVest Advisory LLC purchased a new position in shares of Ventas during the 4th quarter valued at about $26,000. Wiser Advisor Group LLC purchased a new position in shares of Ventas during the 3rd quarter valued at about $27,000. True Wealth Design LLC raised its holdings in shares of Ventas by 1,557.7% during the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust's stock valued at $30,000 after buying an additional 405 shares in the last quarter. Finally, ORG Partners LLC raised its holdings in shares of Ventas by 76.1% during the 3rd quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust's stock valued at $32,000 after buying an additional 197 shares in the last quarter. Hedge funds and other institutional investors own 94.18% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on VTR. Morgan Stanley set a $90.00 price objective on Ventas in a report on Friday, February 13th. KeyCorp raised their price objective on Ventas from $85.00 to $90.00 and gave the company an "overweight" rating in a report on Tuesday, February 10th. Royal Bank Of Canada raised their price objective on Ventas from $83.00 to $91.00 and gave the company an "outperform" rating in a report on Tuesday, February 10th. Wells Fargo & Company raised their price objective on Ventas from $88.00 to $93.00 and gave the company an "overweight" rating in a report on Thursday, March 26th. Finally, UBS Group reissued a "neutral" rating and set a $85.00 price objective on shares of Ventas in a report on Monday, February 9th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Ventas currently has an average rating of "Moderate Buy" and an average target price of $91.73.

Insider Buying and Selling at Ventas

In other news, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president directly owned 72,755 shares in the company, valued at approximately $6,184,175. This trade represents a 32.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.53% of the company's stock.

Ventas Price Performance

VTR opened at $88.11 on Monday. The stock's 50 day simple moving average is $84.79 and its 200 day simple moving average is $80.20. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. Ventas, Inc. has a 1 year low of $61.76 and a 1 year high of $88.41. The firm has a market cap of $42.83 billion, a price-to-earnings ratio of 160.20, a PEG ratio of 2.17 and a beta of 0.74.

Ventas (NYSE:VTR - Get Free Report) last posted its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the business earned $0.84 earnings per share. Ventas's revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, analysts predict that Ventas, Inc. will post 3.85 earnings per share for the current year.

Ventas Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st were given a $0.52 dividend. The ex-dividend date was Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. This is an increase from Ventas's previous quarterly dividend of $0.48. Ventas's dividend payout ratio is 378.18%.

Ventas Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.